Investing in weight-loss drugs, and why everyone’s talking about student loans

On this episode of the AJ Bell Money & Markets podcast, how financial markets reacted to speculation around the future of Keir Starmer as UK prime minister. [02:00] Dan Coatsworth and Tom Sieber unpack the latest results from Shell, BP and Barclays. [05:05] AI has haunted parts of the stock market once again, with financial comparison websites and insurance brokers the latest victims as investors fear major disruption to their business. [11:12] There was some remarkable news in the pharmaceutical space as Novo Nordisk battled Him & Her’s amid controversy around the launch of copycat weight-loss drugs. The pod team explore the weight loss drug space in more detail and explain why one analyst thinks Greggs is a major loser as people slim down. [15:05] Dan talks to Trevor Polishchuk from Worldwide Healthcare about how Eli Lilly has scored the top slot in the weight-loss drug market [24:13]. Martin Gamble chats to Oliver Kenyon from RTW Investment about other names to watch in this space. [30:13] Charlene Young is on the show to explain why everyone’s talking about student loans. [33:00] Finally, Danni Hewson talks to Pathos Communications about its experiences of listing on the UK stock market and the use of AI in the public relations industry. [45:32]

You can listen to Investing in weight-loss drugs, and why everyone’s talking about student loans online on Radio and Podcast. Open the player on this page to stream the available audio.

Investing in weight-loss drugs, and why everyone’s talking about student loans is an episode from AJ Bell Money & Markets by AJ Bell.

This episode is 61:17 long.

This episode was published on Feb 13, 2026.

Yes. Use the heart button on the episode page to add it to your favorite episodes list.

Yes. This page shows related episodes from AJ Bell Money & Markets when more episodes are available from the podcast feed.